Equites Radar

CAH · Cardinal Health, Inc.

Medical DistributionUnited StatesAnalyst view: Strong Buy

$228.03

+1.38% last session

End-of-day data · updated 2026-07-28

Bullish4 bullish · 1 bearish technical signals
Consensus: Strong Buy (1.47 from 15 analysts)
To mean target: +10.7%

Market cap

$54B

Enterprise value

$59B

Trailing P/E

35.1

Forward P/E

19.0

Dividend yield

1.0%

Beta

0.49

Avg volume

2M

Employees

53K

2D change

0.58%

5D change

1.49%

10D change

0.36%

30D change

-3.39%

60D change

16.79%

MTD change

-3.52%

YTD change

12.40%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.47
Covering analysts15
Mean price target$252.40
Low price target$215.00
Upside to mean target+10.7%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)56.8
50-day MA$218.90
200-day MA$206.41
Price vs 50-day MA+6.2%
Price vs 200-day MA+12.6%
MACD histogram-1.27
Volume vs 3-month avg1.1×
52w low $144.5452w high $239.71

Analyst sentiment over time — CAH

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-24

Latest call per bank · past 12 months

Citigroup

Buy

$265

+16.2% vs price
▲ raised from $245Maintains · 2026-07-24

UBS

Buy

$274

+20.2% vs price
▲ raised from $260Maintains · 2026-07-20

Bank of America

Buy

$260

+14.0% vs price
▲ raised from $240Maintains · 2026-07-02

JP Morgan

Neutral

$215

-5.7% vs price
▼ cut from $243Maintains · 2026-05-04

Wells Fargo

Overweight

$245

+7.4% vs price
▼ cut from $256Maintains · 2026-05-01

Barclays

Overweight

$258

+13.1% vs price
▲ raised from $243Maintains · 2026-02-24

Morgan Stanley

Overweight

$245

+7.4% vs price
▲ raised from $224Maintains · 2026-01-29

Recent rating actions

DateFirmActionRatingPrice target
2026-07-24CitigroupMaintainsBuy$245 $265
2026-07-23MizuhoMaintainsOutperform$235 $240
2026-07-20UBSMaintainsBuy$260 $274
2026-07-09TD CowenMaintainsBuy$255 $275
2026-07-02Bank of AmericaMaintainsBuy$240 $260
2026-05-04JP MorganMaintainsNeutral$243 $215
2026-05-01CitigroupMaintainsBuy$249 $245
2026-05-01TD CowenMaintainsBuy$251 $255

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 57 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 6.2% above the 50-day MA ($218.90).
  • Price vs 200-day MA: Trading 12.6% above the 200-day MA ($206.41).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-1.27) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($239.71).

CAH Price Chart

Loading chart for CAH

Fundamentals

Revenue (TTM)$251B
EBITDA$4.0B
Free cash flow$5.0B
Operating cash flow$5.0B
Book value / share$-12.05
Net debt / EBITDA1.3
WACC7.0%
Revenue growth11.00%
Earnings growth-20.00%

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

More in Medical Distribution

Screen CAH against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.